Plain-English translation of NCT06642675 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing navigated transcranial magnetic stimulation (nTMS) — a non-invasive procedure that uses magnetic pulses to stimulate a specific region of the brain — to see if it can help reduce negative symptoms of schizophrenia. Negative symptoms include things like reduced motivation, difficulty speaking, and emotional flatness. Researchers want to know if this brain stimulation treatment can provide relief when combined with standard care.
Many people with schizophrenia struggle with negative symptoms that don't respond well to current medications. This trial exists to explore whether this non-invasive brain stimulation approach could be a helpful additional treatment option for these difficult symptoms.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you would come to the clinic 5 times per day for 10 days to receive brain stimulation sessions, with each session lasting about 10 minutes. You would be randomly assigned to receive either active treatment or a sham (placebo) treatment that feels similar but doesn't deliver the full magnetic pulse. The research team will measure your symptoms before treatment starts, at the end of the 10 days, and again one month later. You're also welcome to continue follow-up visits after the first month if you want to see how long any benefits last.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
China